Natraj Proteins Ltd Stock Hits 52-Week Low Amid Continued Downtrend

Stock Price Movement and Volatility

On 14 Jan 2026, Natraj Proteins Ltd opened with a gap up of 3.91%, reaching an intraday high of Rs.31.9. However, the stock reversed sharply to touch its intraday low and new 52-week low of Rs.28.4, representing a decline of 7.49% from the previous close. The day’s trading was marked by high volatility, with an intraday price fluctuation of 5.8% based on the weighted average price. Despite the initial positive opening, the stock underperformed its sector by 6.94% and closed with a day change of -6.84%.

The recent five-day losing streak has resulted in a cumulative return of -12.62%, underscoring the sustained negative sentiment. The stock currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend.

Comparative Market Context

While Natraj Proteins Ltd has struggled, the broader market has shown resilience. The Sensex, after an initial negative opening down by 269.15 points, recovered to close marginally higher at 83,657.04, up 0.04%. The benchmark index remains within 2.99% of its 52-week high of 86,159.02. Small-cap stocks led the market gains, with the BSE Small Cap index rising by 0.31%. However, Natraj Proteins Ltd’s one-year performance starkly contrasts with the Sensex’s 9.36% gain, having delivered a negative return of -31.94% over the same period.

Financial Performance and Fundamental Assessment

The company’s financial metrics reveal ongoing challenges. For the nine months ended September 2025, net sales declined by 23.59% to Rs.76.54 crores. The quarterly PBDIT (Profit Before Depreciation, Interest and Taxes) stood at a loss of Rs.1.02 crore, with the operating profit to net sales ratio at a low of -3.79%. These figures highlight subdued revenue growth and profitability pressures.

Return on Equity (ROE) averaged 6.97%, indicating modest profitability relative to shareholders’ funds. Additionally, the Return on Capital Employed (ROCE) is reported at 1%, reflecting limited efficiency in generating returns from capital invested. Despite these challenges, the company’s valuation metrics suggest some attractiveness; the enterprise value to capital employed ratio stands at 0.6, indicating the stock trades at a discount relative to its capital base and peers’ historical valuations.

Over the past year, while the stock price has declined by nearly 32%, reported profits have increased by 55.3%, suggesting some improvement in earnings despite the share price weakness. The majority of the company’s shares are held by non-institutional investors, which may influence trading dynamics and liquidity.

Rating and Market Sentiment

MarketsMOJO assigns Natraj Proteins Ltd a Mojo Score of 14.0, categorising it as a Strong Sell. This rating was upgraded from a Sell grade on 31 Jul 2025, reflecting a deterioration in the company’s fundamental strength and market outlook. The market capitalisation grade is rated at 4, indicating a relatively modest market cap within its sector.

The stock’s consistent underperformance against benchmarks is notable. Over the last three years, Natraj Proteins Ltd has underperformed the BSE500 index annually, with the most recent one-year return at -31.94%. This trend highlights persistent challenges in maintaining competitive performance within the edible oil sector.

Valuation and Peer Comparison

Despite the negative price trajectory, valuation metrics suggest the stock is trading at a discount compared to its peers’ historical averages. The enterprise value to capital employed ratio of 0.6 is relatively low, which may reflect market caution but also indicates potential value relative to the company’s asset base. However, the low ROE and ROCE figures temper this valuation advantage, signalling limited profitability and capital efficiency.

The edible oil sector itself has experienced mixed performance, with some companies benefiting from favourable commodity prices and demand trends. Natraj Proteins Ltd’s current position contrasts with these sector dynamics, as it continues to face headwinds in sales and profitability.

Summary of Key Metrics

To summarise, Natraj Proteins Ltd’s stock has reached a new 52-week low of Rs.28.4, reflecting ongoing pressures from declining sales and profitability. The company’s financial indicators, including a negative PBDIT margin and subdued ROE, highlight challenges in generating returns for shareholders. The stock’s valuation metrics suggest some discount relative to peers, but this is offset by weak fundamental performance and consistent underperformance against market benchmarks.

The broader market environment remains positive, with the Sensex near its 52-week high and small caps leading gains. However, Natraj Proteins Ltd’s share price trajectory diverges sharply from these trends, underscoring company-specific factors influencing investor sentiment and trading activity.

Unlock special upgrade rates for a limited period. Start Saving Now →